Acute Myeloid Leukemia
European Commission Grants "Orphan" Status for Treatment
Published in Cancer Weekly, December 12th, 2000
The Commission decision follows a positive opinion adopted on September 13, 2000, by the Committee on Orphan Medicinal Products (COMP) of the European Agency for the Evaluation of Medicinal Products (EMEA).
"We anticipate that Mylotarg will become an important treatment option for European patients age 60 and over with CD33-positive relapsed acute myeloid leukemia (AML)," said L. Patrick Gage, PhD, Wyeth-Ayerst Research. "Its mechanism of action focuses on using antibody-antigen...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2000-12-12)
More Articles from Cancer Weekly
- Breast Cancer
New Susceptibility Gene - ATR - Identified - Breast Cancer
Abnormal Gene Silencing May Lead to Disease Progression - Cell Biology
Scientists Give Golgi Apparatus its Own Identity - Head and Neck Cancer
Amifostine Effective for Prevention of Radiotherapy Side Effects - Head and Neck Cancer
Cell Studies May Further Gene Therapy Prospects - Head and Neck Cancer
Hemoglobin Levels Can Help Predict Chemoradiation Therapy Outcome - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
